Month: December 2017

Adimarket announces agreement with Alolotl Biologix

Adimarket, a subsidiary of Global Stem Cells Group, has announced an agreement with biotechnology company Alolotl Biologix to distribute biological products for regenerative medicine applications worldwide.

 

Adimarket, a subsidiary of Global Stem Cells Group (GSCG), and its subsidiary has announced an agreement with Phoenix, Arizona-based Alolotl Biologix to distribute the biotechnology company’s products for regenerative medicine applications worldwide.

 

Alolotl Biologix focuses on research to optimize the use of human biologicals and to develop biological-related products to foster regeneration and healing for a range of conditions, including orthopedic impairments, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more.

 

Adimarket will make the following amniotic liquid products available to qualified practitioners through its online store www.adimarket.net:

 

AxoBioFluid® C Amniotic Allograft Cryopreserved Liquid, cryopreserved liquid allograft derived from the amniotic membrane that provides structural tissue to advance soft tissue repair, replacement, and reconstruction. Product details:

 

Human allograft under FDA regulation 21 CFR Part 1271 and section 361 of the PHS
Immune privileged with anti-inflammatory and anti-bacterial properties
A rich source of growth factors, proteins, cytokines, hyaluronic acid, and collagen scaffolds
Contains extracellular matrix components for cellular attachment and proliferation
Cryopreserved for an extended shelf life
AxoBioFluid® physician benefits

 

Procedures are efficient and do not require special instrumentation.
• The use of AxoBioFluid® is billed as patient pays, which makes it a great alternative revenue source.
• A library of research papers to demonstrate efficacy degenerated tissue is provided.
AxoBioFluid® patient benefits

 

Relevant Conditions

 

AxoBioFluidâ C Amniotic Allograft Cryopreserved Liquid, cryopreserved liquid allograft derived from the amniotic membrane that provides structural tissue to advance soft tissue repair, replacement, and reconstruction. Product details:

 

Human allograft under FDA regulation 21 CFR Part 1271 and section 361 of the PHS
Immune privileged with anti-inflammatory and anti-bacterial properties
A rich source of growth factors, proteins, cytokines, hyaluronic acid, and collagen scaffolds
Contains extracellular matrix components for cellular attachment and proliferation
Cryopreserved for an extended shelf life
AxoBioFluidâ physician benefits

 

Procedures are efficient and do not require special instrumentation.
• The use of AxoBioFluid® is billed as patient pays, which makes it a great alternative revenue source.
• A library of research papers to demonstrate efficacy is provided.
AxoBioFluid® Amniotic Allograft Cryopreserved Liquid is a cryopreserved liquid allograft derived from the placental components of the amnion to advance soft tissue repair, replacement, and reconstruction. It is classified as minimally manipulated under FDA regulation 21 CFR Part 1271 and section 361 of the PHS. Benefits of AxoBioFluid® AxoBioFluid® is a human allograft fluid derived from the amniotic layer of the placenta. The two primary cell lines which reside in the amnion are human mesenchymal stromal cells (hMSC) and human amnion epithelial cells (hAEC). Both of these cells are considered to be pluripotent stem cells. AxoBioFluid® contains growth factors released while amniotic cells are grown in culture such as epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), and transforming growth factor – beta (TGF-β). These proteins are essential for fetal growth and development and express significant therapeutic benefits when used as a treatment for various injuries and degenerative conditions. AxoBioFluid® is immuneprivileged, anti-inflammatory, anti-fibrotic, pro-vascular, and cytoprotective because of the cells being sourced from the amnion. These secreted factors also signal endogenous progenitor cells to promote regeneration and repair of damaged or degenerated tissue.

 

AxoBioFluid

 

Degenerative disorders such as osteoarthritis
• Joint pain
• Inflammatory conditions such as:
Bursitis
Tendonitis
Fasciitis
Epicondylitis
Soft tissue injuries such as:
Ligament & Tendon sprains
Muscle & Meniscus tears
Wound Care
AxoBioMembrane, a dehydrated allograft membrane patch derived from the amnion that advances wound repair, skin replacement, and reconstruction. Product details:

 

Human allograft under FDA regulation 21 CFR Part 1271 and section 361 of the PHS
Immune privileged with anti-inflammatory and anti-bacterial properties
Contains extracellular matrix components for cellular attachment and proliferation
Dehydrated and terminally e-beam sterilized for an extended shelf life.
AxoBioMembraneä Amniotic Allograft Membrane, like all allograft tissue products, has been subjected to recovery microbiological study and has been terminally sterilized with electron beam sterilization. It works by forming fibrin-elastin bonds at the wound site, ensuring excellent wound adherence. This generates a barrier that protects exposed nerve endings from irritants, providing pain relief while creating a favorable environment for tissue repair and regeneration. In addition, the AxoBioMembrane™ prevents excessive moisture loss by creating a vapor barrier at the wound surface. Growth factors present in the membrane are released into the wound bed, promoting angiogenesis leading to new blood supply needed for cellular migration, proliferation and ultimately, wound repair. Infection is one of the biggest concerns with chronic wounds. AxoBioMembrane™ functions as a bacteriostatic agent, which can inhibit the growth of bacteria at the wound site and reduce the rate infection. It has also been reported to have anti-fibrotic properties, which can reduce scarring. The membrane contains glycoprtoteins found exclusively in the amnion. AxoBioMembrane™ lacks specific surface antigens, which make it immune-privileged and anti-inflammatory.

 

AxoBioMembraneä physician benefits

 

Procedures are efficient and do not require special instrumentation.
AxoBioMembrane™ is billed as patient pays, which makes it a great alternative revenue source.
We provide a library of research and white papers to demonstrate efficacy.
AxoBioMembraneä patient benefits:

 

Pain Reduction
Wound Adherence
Less Scarring
Faster Healing
Neovascularization
Wound Barrier
Anti-bacterial
Immune Privileged
AxoBio products are available to purchase on the Adimarket Website.

 

For more information, visit the Adimarket regenerative medicine online store website, email info@stemcellsgroup.com, or call 305-560-5337.

 

About Global Stem Cells Group

 

Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.

 

Press Contact

 

Name: Benito Novas
Phone: +1 305 560 5337
Email: info@stemcellsgroup.com
Website: www.adimarket.net

The Challenge of Lower Extremity Wounds

Wound clinicians across the nation (and the world) are commonly faced with the difficult task of managing lower extremity wounds. Lower extremity wounds come in many different forms. We are not faced with a generic type, but several—in fact, we never know what we’ll be presented with day-to-day …

read more

Navamedic ASA: Enters into partnership agreement for distribution of Zorflex® in Sweden and Finland

Navamedic ASA (OSE: NAVA), the Norwegian medtech and pharmaceutical products company, today announced it has entered into an agreement with Chemviron Carbon Ltd. (Chemviron) for the launch and commercialisation of Zorflex® wound care contact dressings in Sweden and Finland. Zorflex®, a naturally antimicrobial, 100 percent activated carbon wound contact dressing, helps accelerate treatment of a wide range of chronic and non-chronic wounds …..
read more

Hydrogel: An Overused Wound Care Modality?

While I’m on rounds with students I like to ask, “What is the active ingredient of hydrogel?” My query is usually met with puzzled looks. It’s a trick question, because the term “active ingredient” generally applies to pharmacologic agents that undergo metabolic change in biologic systems. The active ingredient of hydrogel which gives this substance its name is water. Compounds are added to thicken the mixture and provide viscosity, such as glycerine. Other ingredients common in cosmetics, such as aloe vera, methyl paraben, hydrogenated castor oil, and propyl paraben, are added to hydrogel depending on the manufacturer …
read more

Meeting report: antimicrobial stewardship in wound management

At the 27th conference of the European Wound Management Association (EWMA), which was held in Amsterdam on May 3–5, 2017, a joint symposium was held between EWMA and the British Society for Antimicrobial Chemotherapy. The symposium was organised into two sessions. The first focused specifically on wound care issues and the second concerned antimicrobial stewardship programmes.
read more (requires account)

Use of ALLEVYN LIFE foam dressing to manage a heavily exudating venous leg ulcer

A 62-year-old man presented with a left lower leg venous ulcer on the shin. The ulcer had high exudate levels, which was resulting in strike-through of dressings and there was some evidence of surrounding skin maceration. Investigations revealed an ankle brachial pressure index (ABPI) of 1.4. ALLEVYN◊ LIFE Non-Bordered foam dressing (Smith & Nephew) was selected to manage and absorb high-levels of exudate and minimise the risk of trauma to the fragile surrounding skin. Multi-layer compression therapy was also used. After 3 weeks, the ulcer had reduced in size and there was a visible improvement in viable skin [Figures 2–5]. The patient found the dressing comfortable with excellent conformability to the lower leg and minimal pain on dressing removal …

read more (requires account)

Device Images Bacteria in Wounds

Smith & Nephew’s MolecuLight iX is designed to detect bacteria in hard-to-heal wounds using only light. MolecuLight i:X is already available in Canada, where its inventor stumbled across the idea for the device. Ralph DaCosta, MD, now a principal investigator at Princess Margaret Cancer Center in Toronto, was a PhD student researching fluorescent imaging of gastrointestinal cancer in 2007. The big, expensive device he was using didn’t produce any green images, which would have indicated cancer, but a red image that he couldn’t identify ….
read more

The Triangle of Wound Assessment

The negative impact of wounds on patients is significant, and includes pain, reduced quality of life and social isolation. Optimal wound healing can reduce the burden of chronic wounds on patients and the health economy. The Triangle of Wound Assessment is a holistic framework that clinicians can use to improve wound assessment, with particular focus on the wound bed, wound edge and periwound skin (World Union of Wound Healing Societies, 2016). This framework can help guide clinicians to select the most appropriate and effective intervention to improve patient outcomes and to ensure prudent use of healthcare resources …
read more (requires account)

My Journey as a Certified Wound, Ostomy and Continence Nurse

Nursing has given me great opportunities; some of them I never imagined possible. I started as a medical surgical nurse in an oncology unit where the treatment of the day was gauze soaked in Dakin’s solution for the management of post op radical neck surgery. I moved on to intensive care, travel nursing, Army nursing, and endoscopy. It was in endoscopy and working with the colorectal surgeons, who helped me get my clinical experience while pursuing a master’s degree in nursing, where I found out that it all could be tied together with a certification in wound, ostomy, and continence (WOC), and a wound care nurse is born!

read more

Skin and tissue trauma caused by self-harm

Patients who deliberately self-harm and cause skin and tissue trauma are increasing in number across primary and secondary care settings (Nice, 2011b). Self-harm has often been considered a taboo subject and an unnecessary burden to the NHS (Kilroy-Findley and Bateman, 2016). Despite the growing need for effective care, services for assessment, diagnosis and intervention are often overstretched and unable to meet the holistic needs of patients who self-harm (National Institute for Health and Care Excellence [NICE], 2011a; Mind, 2013) …
read more (requires account)

the Sandy Grading System for Surgical Wound Dehiscence Classification

The worldwide volume of surgery is considerable, with an estimated 234.2mn major surgical procedures carried out every year (Weiser et al, 2008). While contemporary surgical procedures are relatively safe, complications such as surgical wound dehiscence, although not commonplace, are a major disruptor to patient wellbeing and wound healing outcomes. Moreover, the importance of classification, documentation and reporting of this type of wound must not be underestimated. Accurate diagnosis and reporting of the type of dehiscence and underlying aetiology is key to understanding the extent of the problem. This paper presents a novel classification system that uses a systematic approach for the diagnosis of the type of dehiscence following surgery …

read more (requires account)

Medical grade honey and diabetic ulcers

The prevalence of diabetes is rising globally with increasing budgetary
burdens from the disease and its complications. In resource-limited
environments, affordable treatment strategies are urgently needed. Wound
care utilises diverse modalities, such as hydrogel, polyurethane and alginate
dressings, as well as silver-containing agents. Honey is a well established
treatment and is cost-effective. In a resource-limited setting, the authors detail
a case report whereby the use of an affordable, easy-to-use agent was used
in conjunction with patient education and self-care, which resulted in rapid
wound healing without side-effects …

read more (requires account)

New Study Documents Cost and Impact of Chronic Wounds

October 4, 2017 – A new study published online in the International Society For Pharmacoeconomics and Outcomes Research’s (ISPOR) Value in Health journal demonstrates the economic impact of chronic nonhealing wounds in Medicare patients. The findings highlight the need for Federal research funding, quality measures and reimbursement models that are relevant to wound care. Such measures are not currently included under Centers for Medicare and Medicaid Services (CMS) payment policies, including the Medicare Access and CHIP Reauthorization Act (MACRA).

 

The study, “An Economic Evaluation of the Impact, Cost, and Medicare Policy Implications of Chronic Nonhealing Wounds,” analyzed the Medicare 5% Limited Data Set for calendar year 2014 and determined that chronic nonhealing wounds impact nearly 15% (8.2 million) of Medicare beneficiaries, far more than suggested by previous studies. Furthermore, conservative estimates for total Medicare annual spending for all wound types ranged from $28.1 billion to $31.7 billion. Treatment and management of infected or re-opened (dehisced) surgical wounds account for the highest per-wound costs. Hospital outpatient care drove the highest site-of-service costs, demonstrating the shift from hospital inpatient to outpatient services in the wound care space …

read more

How Diabetes Impacts Wound Healing

For individuals with diabetes, all wounds are a serious health concern and require careful attention. Because of diabetic peripheral neuropathy, skin cuts and blisters often go unnoticed until they become more complicated to heal. In addition, internal wounds such as ingrown toenails, skin ulcers, or calluses can cause breakdown of tissue and an increased risk of infection. Even small cuts and insect bites can cause wound healing difficulties in patients with diabetes. Here are common factors of diabetes that impact wound healing …

read more

Preventative Skin Care in Wound Management

Prevention is one of the most important components of wound and ostomy care. Factors such as hydration, pressure, excessive moisture, cleanliness, and erythema can all affect wound healing rate, patient comfort, and the incidence of new wounds. By taking a proactive stance, health care professionals can reduce the risk of infection, reduce costs, and improve patient outcomes.1

Why Preventative Skin Care is Important

Wounds affect 35% of all hospice patients, and 120,000 new ostomy surgeries are performed each year.2,3 This makes these two of the most prevalent conditions faced by nurses and other health care professionals …

read more

10 Tips for Effectively Bandaging a Wound

Wrapping wounds is an art, and hence, it comes easily to some and more difficult to others. This post won’t make you a wound dressing artist, but it does provide some tips for good bandaging techniques. The word “bandage” (in the US) often refers to a primary dressing, so “wrap” better describes a bandage that is long, narrow, and may be used to secure a primary dressing or obtain graduated compression on a limb.

read more

Daniel D. Caviness, DPM will be Noted in the Worldwide Leaders in Healthcare

The International Association of HealthCare Professionals is pleased to welcome Daniel D. Caviness, DPM to their prestigious organization with his upcoming publication in the Worldwide Leaders in Healthcare. Dr. Daniel D. Caviness is a highly trained and qualified podiatrist currently serving patients within the Chico Podiatry Group in Chico, California and affiliated with Enloe Medical Center. Featuring over two decades of experience in his field, he has a special expertise in foot care, podiatric surgery and podiatric wound care.

read more

AAWC Announces Chief Executive Officer

MALVERN, Pa.Oct. 10, 2017 /PRNewswire-USNewswire/ — The Association for the Advancement of Wound Care (AAWC)announces Victoria E. Elliott, RPh, MBA, CAE, as the new Chief Executive Officer. Ms. Elliott brings a wealth of experience in association management. As a Certified Association Executive (CAE), her qualifications include alliance building, membership growth, volunteer engagement and leadership development. Ms. Elliott has served as Executive Director for the American Neurological Association, Dermatology Nurses’ Association, Attention Deficit Disorder Association, Society For Biomaterials and the Pennsylvania Society of Health System Pharmacists. Most recently she was Director of Development at the University of the Sciences where she focused on individual alumni giving, and student and parent fundraising campaigns.

Victoria E. Elliott, RPh, MBA, CAE, Chief Executive Officer, Association for the Advancement of Wound Care (PRNewsfoto/Association for the Advancement)

read more

The world’s leading, largest, and most well-respected interdisciplinary wound care program within the clinical field. The Symposium on Advanced Wound Care Spring | Wound Healing Society meeting (SAWC Spring | WHS) serves as a forum to connect the entire wound care team — physicians, nurses, physical therapists, researchers, scientists, podiatrists, and dietitians — with the…

Healthcare is Ready for Alexa, as Soon as HIPAA Issue Resolved

A voice-enabled bathroom scale that can scan for diabetic foot ulcers uses Amazon’s voice service, Alexa, to instruct patients to step on when they’re ready to begin. In one test, a patient responded to Alexa’s prompt by declaring, “Ready when you are.”

 

Anne Weiler, co-founder and CEO of Wellpepper, a Seattle company that developed the prototype scale as part of its entry in the Alexa Diabetes Challenge, might say the same thing to Amazon (NASDAQ: AMZN) itself.

 

She’s among those healthcare IT entrepreneurs convinced that the future of healthcare will include human-computer voice interactions—just as soon as Amazon makes its voice services compliant with healthcare privacy laws.

read more

This student has invented a new wound care technology

InMEDBio LLC, a company founded by University of Virginia fourth-year student Ashwinraj Karthikeyan, will be one of six undergraduate entrants to compete in the prestigious Collegiate Inventors Competition in November.

 

The competition has promoted innovation and entrepreneurship among college graduate and undergraduate students since 1990. Not only do participants receive encouragement and feedback, but they compete for cash prizes as well. Since its inception, the event has awarded more than $1 million to college students.

read more

See How Your Smartphone Could Be Used To Activate This Smart Bandage

Smart cars, smart homes, smart cities. We’re living in an era of smart devices that can help us be healthier, safer and live more responsibly. Now, there’s a chance we’ll be able to heal own wounds using a smart bandage we control with our smartphones.

Researchers from the University of Nebraska-Lincoln say they’ve designed a prototype smart bandage that could eventually heal chronic wounds through the medically coated fibers in the bandage.

read more

 

At-Risk Patient: Diabetic Foot Ulcers

Patients with diabetes have a higher risk of ulceration, typically on the lower extremities. Other factors contributing to the risk of foot ulceration include peripheral neuropathyperipheral arterial diseaseinfection and pressure.

Symptoms of Diabetic Foots Ulcers

Neuropathy, a major contributing factor in the development of diabetic foot ulcers, may present as a stinging, burning or shooting pain in the lower extremities that over time may progress to a loss of sensation in the feet or may initially develop as a progressive loss of sensation. This loss of feeling can cause patients with diabetes to further injure their feet and legs, opening them to infection and thus, ulceration.

read more

Review: Comparing the Effectiveness of Cellular and/or Tissue-Based Products for Treating Diabetic Foot Ulcers

One fourth of the approximately 22.3 million patients with diabetes in the United States are expected to develop a diabetic foot ulcer (DFU) at some point during their lives, and it is estimated to affect 1-8% of individuals with diabetes annually. DFUs have shown to be challenging to treat, and often result in extended hospital stays, increased risk of infection, and subsequent amputation in certain patients. A major concern regarding amputees is a 5-year mortality rate that rivals that of patients with colon cancer. In addition, DFUs contribute heavily to the financial load of payers, with an estimated annual medical cost of up to $13 billion.

Prior studies have indicated that wounds that penetrate bone, are prolonged and recurrent, and those associated with peripheral vascular disease pose a great risk for eventual amputation. Studies have shown that, even with proper care of DFUs by podiatric physicians and other clinical personnel, these wounds are slow to heal. Advanced therapies are often explored to improve outcomes.

read more

Wound Care Basics: Understanding Lymphedema and the Lymphatic System

When I talk to my patients with lymphedema, I often need to tell them about their lymphatic system. Beyond knowing of lymph nodes or glands in their neck, most don’t recall having heard anything about it. Surprisingly, today’s medical students often have less than 1 hour on the lymphatic system education in medical school. In physical therapy school (35 years ago), instruction was woefully inadequate. Today, more is known – and most therapy schools do spend significant time on the lymphatic system and lymphedema. For those who missed it, here is the lymphatic system in a nutshell.

The Lymphatic System: An Overview

The lymphatic system includes the thoracic duct (main vessel), which receives the lymph fluid from smaller vessels called lymph collectors. The latter receive lymph fluid from the initial lymphatic vessels read more

Providing Hope to Patients with Wounds

I have written about so many things over the past years… Maybe now is a good time to announce that I am writing a book called Hear Our Cry, an autobiographical story about 20 years of wound care and limb salvage. The process has had quite an impact on me, reviewing all the pictures and notes from my wound patients from the past two decades.

 

The Importance of Hope

 

What a tragedy has been spread out in front of me when I consider all the pain and heartache due to limb wounds and limb loss read more

Wound Consulting Business: How to Get Started

So, you’ve been thinking about starting that wound care business you’ve always dreamed about. What’s next?

First of all, start by taking a look at Wound Consulting Business: Do You Have What It Takes?, to see what factors you should consider before taking the plunge. It’ll help you decide if you’re cut out to be your own boss. Then, if you still think being a wound consultant is for you, let’s talk about getting started … read more